Ligand validation:6W79

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6W79_MES_A_403	80%	16%	0.108	0.956	1.93	1.73	1	4	0	0	100%	0.639
6W79_MES_A_404	75%	18%	0.121	0.953	2	1.54	1	2	0	0	100%	0.667
2V6N_MES_A_2308	64%	1%	0.161	0.959	1.67	5.97	1	9	0	0	100%	0.7
6WCO_MES_A_401	60%	16%	0.149	0.936	1.95	1.74	1	3	0	0	100%	0.637
3SNE_MES_A_2308	48%	1%	0.195	0.939	1.81	5.89	1	11	0	0	100%	0.7
2GT7_MES_B_601	20%	5%	0.185	0.784	2.24	3.13	1	8	2	0	100%	0.5
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
5APG_MES_A_1187	100%	12%	0.044	0.99	1.48	2.57	3	6	0	0	100%	0.9292

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.